HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DOOR syndrome (deafness, onycho-osteodystrophy, and mental retardation): elevated plasma and urinary 2-oxoglutarate in three unrelated patients.

Abstract
We describe three further children with the DOOR syndrome (deafness, onycho-osteodystrophy and mental retardation). A severe seizure disorder and characteristic facial appearance are part of the syndrome. Fourteen similar cases including the present patients are now on record. Autosomal recessive inheritance is likely. An increased level of 2-oxoglutarate in both plasma and urine has been found in our three patients. It is suggested there may be an inherited metabolic defect in this malformation syndrome.
AuthorsM A Patton, S Krywawych, R M Winter, D P Brenton, M Baraitser
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 26 Issue 1 Pg. 207-15 (Jan 1987) ISSN: 0148-7299 [Print] United States
PMID3812564 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ketoglutaric Acids
Topics
  • Abnormalities, Multiple (genetics, metabolism)
  • Bone and Bones (abnormalities)
  • Child, Preschool
  • Deafness (genetics, metabolism)
  • Female
  • Genes, Recessive
  • Humans
  • Infant
  • Intellectual Disability (genetics, metabolism)
  • Ketoglutaric Acids (metabolism)
  • Male
  • Nails, Malformed
  • Seizures (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: